'Omics' Approaches in Cancer Research, W. Cho; 2. Recent Advances in Cancer Genomics and Cancer-Associated Genes Discover, B. Guan, T.-L. Wang, I.-M. Shih; 3. An Integrated Oncogenomic Approach: from genes to pathway analyses, J.A. Klomp, B.T. Teh, K.A. Furge; 4. The Epigenomics of Cancer, I. Hatada; 5. Involvement of MicroRNAs in Human Cancer: discovery and expression profiling, M. Negrini, G. A. Calin; 6. Functional Proteomics in Oncology: a focus on antibody array-based technologies, M. Sanchez-Carbayo; 7. Protein Graphs in Cancer Predictin, H. González-Díaz, G. Ferino, C.R. Munteanu, S. Vilar, E. Uriarte; 8. The Use of Metabolomics in Cancer Research, B. van Ravenzwaay et al.; 9. Interactomics and Cancer, G. Chaurasia, M.E. Futschik; 10. Cytomics and Predictive Medicine for Oncology, A.O.H. Gerstner, G. Valet; 11. The Frontiers of Computational Phenomics in Cancer Research, E. A. Mendonça, Y.A. Lussier; 12. Application of Bioinformatics in Cancer Research, B. Stransky, P. Galante; 13. Translational medicine: application of omics for drug target discovery and validation, X. Zhang, W. Wang, K. Xiao, L. Shi; 14. Integration of omics data for cancer research, L. Martín, A. Anguita, V. Maojo, J. Crespo; Index
William Chi Sing Cho Knihy


Diabetes is a chronic metabolic disorder and complicated disease, and much remains to be learned. This is certainly a medical field in which more insights are needed. The development of high-throughput proteomic technologies permits the solution of deciphering diabetes from higher dimensionality that may provide a knowledgebase which changes the face of diabetes understanding and therapeutics. Ginseng is one of the Chinese medicinal plants with antidiabetic properties. This is the first book to provide an angle covering both proteomics and Chinese medicine researches on diabetes. This book not only serves as an introduction to the topic for novices to the area and a useful reference for those already involved, but also serves as a stimulus to these and others to develop new approaches to the disease. This unique book provides proteomic and medicinal approaches towards diabetes which will appeal to anyone involving in diabetes research - clinicians, diabetes researchers, endocrinologists, pathologists, pharmacologists, and pharmaceutical specialists who want to expand their knowledge in diabetes research.